AU2001256570A1 - Novel anticancer compounds: process for their preparation and pharmaceutical compositions containing them - Google Patents
Novel anticancer compounds: process for their preparation and pharmaceutical compositions containing themInfo
- Publication number
- AU2001256570A1 AU2001256570A1 AU2001256570A AU5657001A AU2001256570A1 AU 2001256570 A1 AU2001256570 A1 AU 2001256570A1 AU 2001256570 A AU2001256570 A AU 2001256570A AU 5657001 A AU5657001 A AU 5657001A AU 2001256570 A1 AU2001256570 A1 AU 2001256570A1
- Authority
- AU
- Australia
- Prior art keywords
- preparation
- pharmaceutical compositions
- compositions containing
- anticancer compounds
- novel anticancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN354/MAS/2000 | 2000-05-05 | ||
| IN354MA2000 | 2000-05-05 | ||
| IN434/MAS/2000 | 2000-06-08 | ||
| IN434MA2000 | 2000-06-08 | ||
| PCT/IB2001/000748 WO2001085710A1 (en) | 2000-05-05 | 2001-05-03 | Novel anticancer compounds: process for their preparation and pharmaceutical compositions containing them |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001256570A1 true AU2001256570A1 (en) | 2001-11-20 |
Family
ID=26324892
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001256570A Abandoned AU2001256570A1 (en) | 2000-05-05 | 2001-05-03 | Novel anticancer compounds: process for their preparation and pharmaceutical compositions containing them |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2001256570A1 (en) |
| WO (1) | WO2001085710A1 (en) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003222445A1 (en) * | 2003-03-31 | 2004-10-25 | Council Of Scientific And Industrial Research | Synergistic hepatoprotective composition and a method thereof |
| US7794753B2 (en) | 2003-03-31 | 2010-09-14 | Council Of Scientific And Industrial Research | Synergistic hepatoprotective composition and a method thereof |
| US8445533B2 (en) | 2004-11-08 | 2013-05-21 | Cornell Research Foundation, Inc. | Andrographolide derivatives to treat viral infections |
| CN103145665B (en) * | 2012-04-12 | 2014-12-31 | 江西青峰药业有限公司 | 17-hydro-9-dehydro-14,17-cyclo-andrographolide-19-sulphate and its preparation method and use in drug preparation |
| CN102716122B (en) * | 2012-07-03 | 2014-06-25 | 郑州大学 | Application of 15-benzal-14-deoxy-11, 12-dehydro-andrographolide derivatives in preparing medicines for treating diabetes mellitus |
| CN103224492B (en) * | 2013-04-15 | 2016-01-13 | 南京工业大学 | 14-aryl-ether andrographolide derivative and its preparation method and application |
| CN104119253B (en) * | 2013-04-24 | 2015-12-09 | 江西青峰药业有限公司 | Pharmaceutical composition of a kind of andrographolidume derivative and preparation method thereof and purposes |
| CN104119251B (en) * | 2013-04-24 | 2015-12-09 | 江西青峰药业有限公司 | 9-dehydrogenation-rographolide-17-sulfonic acid-16-carboxylic acid or its salt, preparation method and prepare pharmaceutical use |
| US20170354639A1 (en) * | 2014-10-24 | 2017-12-14 | Biogen Ma Inc. | Diterpenoid derivatives and methods of use thereof |
| CN106432153B (en) * | 2016-10-13 | 2019-02-19 | 四川理工学院 | A kind of sulfur-bearing andrographolidume derivative, its pharmaceutical composition, synthetic method, the application in preparation treatment prostate cancer drug |
| CN109568265B (en) * | 2017-09-28 | 2021-09-28 | 神威药业集团有限公司 | Andrographolide nanosuspension |
| CN108129468B (en) * | 2018-01-29 | 2020-09-29 | 四川理工学院 | Aspirin derivatives and preparation method and application thereof |
| CN108084122B (en) * | 2018-01-30 | 2021-05-07 | 北海开元生物科技有限公司 | Method for extracting high-purity andrographolide |
| CN108904446B (en) * | 2018-06-11 | 2021-05-11 | 中山大学 | Preparation method and application of drug-loaded nano-micelle responding to arterial plaque microenvironment |
| CN113173896A (en) * | 2021-04-14 | 2021-07-27 | 张洪胜 | Ferulic acid derivative with antioxidant activity and preparation method thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8917295D0 (en) * | 1989-07-28 | 1989-09-13 | Ruffles Graham K | Anti-viral compositions |
| AU4376396A (en) * | 1994-12-06 | 1996-06-26 | Paracelsian, Inc. | Use of andrographolide compounds to treat or prevent pathogenicity of diseases |
| US5833994A (en) * | 1997-01-08 | 1998-11-10 | Paracelsian, Inc. | Use of the AH receptor and AH receptor ligands to treat or prevent cytopathicity of viral infection |
| JP2003516950A (en) * | 1999-12-14 | 2003-05-20 | エイボン プロダクツ インコーポレーテッド | Skin care compositions that mediate cell-to-cell communication |
-
2001
- 2001-05-03 WO PCT/IB2001/000748 patent/WO2001085710A1/en active Application Filing
- 2001-05-03 AU AU2001256570A patent/AU2001256570A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001085710A1 (en) | 2001-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0203107A3 (en) | Novel spiro compounds, process for their preparation and pharmaceutical compositions containing them | |
| HUP0301187A3 (en) | Novel benzyl-piperidine-derivatives, process for their preparation and pharmaceutical compositions containing them | |
| HUP0301069A3 (en) | Novel biarylcarboxamides, process for their preparation, pharmaceutical compositions containing them and their use | |
| HUP0204496A3 (en) | Novel piperidine compounds and pharmaceutical compositions containing the same and process for preparation the same | |
| HUP0201376A2 (en) | Thiazoloderivatives and pharmaceutical compositions containing them and process for preparation the compounds | |
| HUP0302519A3 (en) | Crystalline forms of atorvastatin, process for their preparation and pharmaceutical compositions containing them | |
| HUP0402225A3 (en) | Macrolide-compounds, process for their preparation and pharmaceutical compositions containing them | |
| AU2001258677A1 (en) | Novel compounds having antiinflammatory activity: process for their preparation and pharmaceutical compositions containing them | |
| HUP0201206A2 (en) | Antibacterial compounds, process for their preparation and pharmaceutical compositions containing them | |
| AP2002002575A0 (en) | Compounds having hypolupedemic and hypocholestermic activities process for their preparation and pharmaceutical compositions containing them | |
| HUP0201402A3 (en) | Bis-sulfonamides, process for their preparation and pharmaceutical compositions containing them | |
| AU2001256570A1 (en) | Novel anticancer compounds: process for their preparation and pharmaceutical compositions containing them | |
| HUP0400926A3 (en) | Lipid lowering new biphenylcarboxamides, process for their preparation and pharmaceutical compositions containing them | |
| HUP0100489A3 (en) | New piperidine-4-sulphonamide compounds, process for their preparation and pharmaceutical compositions containing them | |
| HUP0302912A3 (en) | Betha-thio-amino acids, process for their preparation and pharmaceutical compositions containing them | |
| HUP0302515A3 (en) | Sulfanidothienopyrimidines, process for their preparation and pharmaceutical compositions containing them | |
| AU2002348829A1 (en) | Novel compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them | |
| HUP0301254A3 (en) | Novel compounds, process fo their preparation and pharmaceutical compositions containing them | |
| HUP0204001A3 (en) | Substituted aminomethyl-phenyl-cyclohexane derivatives, process for their preparation and pharmaceutical compositions containing them | |
| HUP0303361A3 (en) | Substituted 1-aminobutan-3-ol derivatives, process for their preparation and pharmaceutical compositions containing them | |
| HUP0401082A3 (en) | Substituted 4-aminocyclohexanols, process for their preparation and pharmaceutical compositions containing them | |
| AU2001256568A1 (en) | New compounds having anticancer activity: process for their preparation and pharmaceutical compositions containing them | |
| AU2002306687A1 (en) | Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them | |
| HUP0201024A3 (en) | Izoindeindolone compounds, process for their preparation and pharmaceutical compositions containing them | |
| HUP0302905A3 (en) | Triazolo-epothilone-analogs, process for their preparation and pharmaceutical compositions containing them |